Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Transition Therapeutics Inc

+ Add to Watchlist

TTHI:US

7.9000 USD 0.2000 2.60%

As of 20:10:00 ET on 04/17/2015.

Snapshot for Transition Therapeutics Inc (TTHI)

Open: 7.6500 Day's Range: 7.6000 - 8.0000 Volume: 81,136
Previous Close: 7.7000 52wk Range: 4.3600 - 8.0000 1-Yr Rtn: +41.32%

Stock Chart for TTHI

No chart data available.
  • TTHI:US 7.9000
  • 1D
  • 1M
  • 1Y
7.7000
Interactive TTHI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TTHI

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (06/2015) -1.3350
Est. PEG Ratio -
Market Cap (M USD) 306.96
Shares Outstanding (M) 38.86
30 Day Average Volume 24,012
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TTHI

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for TTHI

Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.

Tony F CruzChairman/CEONicole Rusaw GeorgeChief Financial Officer
Carl DamianiChief Operating OfficerAleksandra PastrakVP:Clinical Dev/Medical Ofcr
More Company Profile & Key Executives for TTHI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil